AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Docet RTU 20mg/0.5ml Injection

Prescription Icon
Prescription Required

Marketer

Samarth Life Sciences Pvt Ltd

Salt Composition

Docetaxel (20mg/0.5ml)

Overview Docet RTU 20mg/0.5ml Injection

Docetaxel 20mg/0.5ml Ready-to-Use Injection is a chemotherapy agent indicated for treating various cancers, including breast, non-small cell lung, prostate, and head and neck cancers. Administration is strictly via intravenous injection by a healthcare professional. Dosage and frequency are determined by your oncologist, tailored to your specific condition and may be adjusted. Adhere precisely to your physician's instructions; improper use or overdose can lead to severe adverse reactions. Therapeutic benefits might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling (edema), infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Concomitant medication may be prescribed to mitigate these effects. Report any unusual bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are mandatory to monitor blood cell levels and liver function. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, to your doctor. Significant drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout the treatment period.

Primary Ingredients of Docet RTU 20mg/0.5ml Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Docet RTU 20mg/0.5ml Injection

Cancers affecting the breast, lungs (non-small cell), prostate, and head/neck.

Major Benefits of Docet RTU 20mg/0.5ml Injection:

This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.

Common Side effects of Docet RTU 20mg/0.5ml Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Docet RTU 20mg/0.5ml Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Docet RTU 20mg/0.5ml Injection works:

Docetaxel 20mg/0.5ml ready-to-use injection is a chemotherapeutic agent. Its mechanism of action involves disrupting microtubules, essential components of cancer cell division. This inhibition of microtubule function arrests cancer cell proliferation, leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Docet RTU 20mg/0.5ml Injection and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Docet 20mg/0.5ml RTU Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, a physician may prescribe it. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Administering Docet 20mg/0.5ml injection (ready-to-use formulation) to breastfeeding individuals is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Docet RTU 20mg/0.5ml Injection is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Docet RTU 20mg/0.5ml Injection presents no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Caution is advised when administering Docet RTU 20mg/0.5ml Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Docet RTU 20mg/0.5ml Injection :

NA

Facts to Know About Docet RTU 20mg/0.5ml Injection

LabelValue
Chemical Type Taxane-Based Drugs
Developing Habits No.
Treatment Category Cancer Medications
Action Class Taxanes: Antimicrotubule Agents

FAQs on Docet RTU 20mg/0.5ml Injection

Yes, Docet RTU 20mg/0.5ml injections can cause weight gain, often starting with swollen feet due to fluid retention, which may then spread throughout the body. Contact your doctor immediately if you experience foot swelling.
Continue taking your Docet RTU 20mg/0.5ml Injection as directed by your doctor. Treatment length depends on your cancer type and your response to therapy, with infusions typically given every three weeks.
Docet RTU 20mg/0.5ml Injection contains alcohol, which can cause drowsiness, confusion, dizziness, and a feeling of intoxication. This may affect your ability to operate machinery or drive immediately after injection. Therefore, avoid alcohol consumption during treatment with Docet RTU 20mg/0.5ml Injection to prevent adverse effects.
Docet RTU 20mg/0.5ml Injection treats various cancers, including breast, lung, prostate, stomach, and head and neck cancers, by inhibiting cell growth and proliferation.
Docet RTU 20mg/0.5ml Injection is a liquid administered intravenously by healthcare professionals in a clinical setting. Infusion typically takes one hour, and it's administered once every three weeks.
Before each dose of Docet RTU 20mg/0.5ml Injection, your doctor will order blood tests, including a hemogram and liver function tests, to monitor your blood cell count and liver function. Low white blood cell counts can cause fever or infection.
Docet RTU 20mg/0.5ml Injection may cause hair loss, a common side effect. Hair usually regrows after treatment ends, but permanent hair loss is possible. Discuss any hair loss concerns with your doctor.
Docet RTU 20mg/0.5ml Injection can cause fluid retention (swelling in extremities) and severe allergic reactions. To mitigate these risks, all patients receive corticosteroids (dexamethasone) for three days, beginning one day before injection. For metastatic castration-resistant prostate cancer, dexamethasone is administered orally 12, 3, and 1 hour before Docet RTU 20mg/0.5ml infusion.
Docet RTU 20mg/0.5ml Injection, a taxoid anticancer medication, inhibits cancer cell growth and spread.
Docet RTU 20mg/0.5ml Inje...
2,200
MRP 2,553
13% off